Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)

9 Mar 2024

Abstract excerpt

Genomic tumor testing (GTT) is an emerging technology aimed at identifying variants in tumors that can be targeted with genomically matched drugs. Due to limited resources, rural patients receiving care in community oncology settings may be less likely to benefit from GTT. We analyzed GTT results and observational clinical outcomes data from patients enrolled in the Maine Cancer Genomics Initiative (MCGI), which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genomics and Rare Diseases
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38461318
DOI: 10.1038/s41698-024-00547-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (MCGI)PMID 38461318Read ↗

Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven OncologySemantic proximity Read ↗

Real-world clinical utility and challenges of comprehensive genomic profiling for advanced solid tumors in a community health institution.Semantic proximity Read ↗

Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.Semantic proximity Read ↗

Characterization of Oncology Clinical Trials Using Germline Genetic DataSemantic proximity Read ↗

Clinical Outcomes of Genotype-Matched Therapy For Recurrent Gynecological CancersSemantic proximity Read ↗

Determinants of Targeted Cancer Therapy Use in Community Oncology Practice: A Qualitative Study using the Theoretical Domains Framework and Rummler-Brache Process MappingSemantic proximity Read ↗

Targeted Therapy Improves Real-World Survival in Patients with Molecularly Matched Advanced Biliary Tract CancerSemantic proximity Read ↗

Comparative Effectiveness Research, Genomics-Enabled Personalized Medicine, and Rapid Learning Health Care: A Common BondSemantic proximity Read ↗

Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial.Semantic proximity Read ↗

Incorporating Real-World Clinico-Genomic Insights to Inform Diversity Enrollment Targets in Oncology TrialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.